Trial record 1 of 4 for:    04-21
Previous Study | Return to List | Next Study

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts (ONTIME)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
The Leukemia and Lymphoma Society
Information provided by (Responsible Party):
Onconova Therapeutics, Inc.
ClinicalTrials.gov Identifier:
NCT01241500
First received: November 1, 2010
Last updated: August 1, 2016
Last verified: August 2016